Financials
- Market Capitalization 23.77 M
- Employee 40
- Founded 2015
- CEO N/A
- Website www.nextcure.com
- Headquarter Delaware, United States
- FIGI BBG00BTH5153
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.72
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4548 | MRKR Marker Therapeutics, Inc. - Common Stock | 1.44 USD | -1.37% | -13.77% | +6.67% | -8.28% | 24.01 M USD | ||
| 4550 | NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 0.73 USD | 0.00% | +7.35% | +5.80% | -64.73% | 23.77 M USD | ||
| 4553 | VYNE VYNE Therapeutics Inc. - Common Stock | 0.71 USD | +7.58% | +9.23% | +16.39% | -46.21% | 23.68 M USD | ||
| 4581 | CELU Celularity Inc. - Class A Common Stock | 0.76 USD | 0.00% | 0.00% | -2.56% | -64.49% | 22.00 M USD |